Wörwag Pharma announces that Lucia Cinque will join the company as Managing Director on June 1, 2021. In the newly created role of Chief Innovation Officer (CINO), she will lead the company together with Jochen Schlindwein, CEO, and Gerhard Mayer, CFO.
The decision to add this role to the executive management team underlines the company's growth ambitions and goal to sustainably contribute to the expansion of its product portfolio as well as the provision of new healthcare solutions by investing in its innovation and development capabilities.
Lucia Cinque, who holds a PhD in Biomedical Engineering, brings experience from senior positions in R&D and innovation management of healthcare technology companies; most recently she was co-founder of a startup in this sector. In her positions, she dealt in depth with innovative growth opportunities and their translation into viable business models.
Prof. Dr. Roderich C. Thümmel, Chairman of the Advisory Board, warmly welcomes Lucia Cinque on behalf of the Advisory Board: "We are pleased to win such a proven innovator and experienced manager for the Wörwag’s Management Board in Ms. Cinque. We are convinced that she will raise Wörwag's innovation agenda to a new level. This will help to expand our product portfolio, maintain our market leadership in biofactors and further foster the innovation mindset in our organization."
